A case of Ebstein's anomaly associated with chronic right heart failure, hepatosplenomegaly, and the haematological features of hypersplenism is presented. The haematological abnormalities were corrected after tricuspid valve replacement but recurred with the reemergence of clinical features of right heart failure.
Case report Ebstein's anomaly was diagnosed in a child with cyanosis on exertion, characteristic physical findings, and radiological evidence of cardiomegaly. He remained well, however, without treatment, until the age of 35 when he presented with dyspnoea and epistaxis. On examination he had cyanosis at rest, features of right heart failure with tricuspid regurgitation, hepatosplenomegaly, and widespread purpura. Investigations performed at that time showed a haemoglobin concentration of 188 g/l ( The tricuspid valve was replaced with a Starr-Edwards prosthesis two years after valvoplasty and his clinical signs of right heart failure resolved with a considerable improvement in symptoms. This was associated with a dramatic reduction in his hepatosplenomegaly as assessed clinically and on abdominal radiography and a sharp rise in his neutrophil and platelet counts, which restored them to normal (figure). Between 1978 and 1989 signs of right heart failure gradually reemerged with progressive hepatosplenomegaly and concomitant falls in his neutrophil and platelet counts (figure). Cardiac catheterisation showed a further increase in right sided pressures ( and was corrected by closure of the shunt. Our patient with Ebstein's anomaly had had chronic right heart failure with raised systemic venous pressures for many years.
Chronic right heart failure with hepatic venous congestion is associated with splenomegaly in 12-25% of patients5; the mechanism is believed to be portal venous hypertension secondary to raised hepatic venous pressures. Moderate to severe symptoms in Ebstein's anomaly or the presence of heart failure are regarded as indications for tricuspid valve plication or replacement.6 Replacement has been shown to reduce right atrial pressures,6 and should therefore reduce both systemic and portal venous pressures. Reduction in portal venous pressures, for example after distal spleno-renal shunting procedures, reversed the neutropenia and thrombocytopenia of hypersplenisifn and this was associated with a reduction in splenic size.78
Hypersplenism in our patient seems to be the result of raised systemic (and thus portal) venous pressures, and treatment of the cardiac lesion with reduction in these pressures improved the secondary haematological characteristics. Such an association between Ebstein's anomaly and hypersplenism has not been described before; perhaps because detailed longitudinal studies over many years are often not possible. Our patient is also unusual because he has survived 17 years after the onset of heart failure-a poor prognostic sign in patients with Ebstein's anomaly. 
